Refine by
Injectable Long Articles & Analysis
11 news found
The company's microsphere manufacturing technologies cover a wide range of aspects, including membrane emulsification and sedimentation technology, microfluidic technology, membrane emulsification technology, emulsification and volatilization technology, phase separation technology, spray drying technology, and hot melt extrusion technology. Long-Acting Controlled-Release ...
” Today, biologics are predominantly delivered via injection or intravenous infusion, which limits long-term treatment adherence, often leading to suboptimal patient outcomes. ...
CJ Wang, CEO, Frontier Biotechnologies said, "Today's announcement marks an important milestone in our efforts to create a long-acting injectable for treatment-experienced PLHIV (Patients Living with HIV) and critically ill, hospitalized AIDS patients who have limited choices for antiretroviral treatment. ...
Emerson, Joins Contraline Board New Board appointment strengthens Contraline with world-class expertise in urology device development, approvals, commercial strategy, and business development Charlottesville, VA – Contraline, Inc., a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has ...
Contraline, a spin-out from UVA, is a medical device company developing ADAM™, the world’s first injectable hydrogel designed to provide long-lasting barrier contraception for men. ...
Contraline, a spin-out from UVA, is a medical device company developing ADAM™, the world’s first injectable hydrogel designed to provide long-lasting barrier contraception for men. ...
Progression of Type 2 Diabetes Treatment Due to natural progression of type 2 diabetes, maintenance of glycemic targets requires a stepwise approach to treatment in order to achieve and maintain glycemic control and avoid complications1'2 Comprehensive lifestyle modifications combined with metformin Addition of up to 3 oral medications or GLP-1 RA injection Addition of ...
The Lumee Oxygen Platform is a tiny, injectable tissue-integrated biosensor with an intelligent data platform intended for continuous, real-time monitoring of tissue oxygen levels. ...
The Lumee Oxygen sensor provides continuous and long-term monitoring of the oxygen in subcutaneous tissue. After a single injection, measurement thereafter is obtained non-invasively using an optical reader. ...
Our team has developed a vas-occlusive hydrogel that is easily injectable, safe, and long-lasting. The key innovation is that we designed the hydrogel specifically for the vas environment and the occlusion of sperm. ...
Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented the development of in-body sensors capable of continuous, long-term monitoring of body chemistry. But today scientists are presenting results showing tiny biosensors that become one with the body have overcome this barrier, and stream data to a mobile phone and to ...